Digital health case studyPharmaceutical

Pressure-Testing an Existing Digital Health Portfolio for Fitness to Scale

Client context: Leading global pharmaceutical

Strategic question

Is our existing Digital Health portfolio fit for purpose against our updated franchise strategy?

Decision enabled

What the client could do next

Enabled franchise leadership to re-prioritise, retire or deepen existing partnerships with confidence.

Approach

Working closely with franchise and BD teams, we used HealthTech Alpha to evaluate 70+ existing venture partnerships against clinical, commercial and operational maturity criteria.

Methodology

DefineClarified the strategic question, scope, decision owner and evaluation criteria.

MapIdentified relevant ventures, markets, competitors, partnerships and ecosystem signals.

AssessEvaluated maturity, traction, evidence, strategic fit and operational readiness.

DecideTranslated findings into a decision-ready shortlist, benchmark or recommendation.

Strategic interpretation

Surfaced which partnerships were genuinely scaling value, which were underperforming and which had become strategically misaligned.

Key results

70+Partnerships evaluated

3Clinical, commercial and operational dimensions

1Franchise-level strategy reset

Structured digital health intelligence, venture evidence, and analyst interpretation for defensible decisions.

Alpha Brief

Turn this case study into your own decision brief

Answer a few prompts and request a scoped Alpha Brief for your market, portfolio, competitive intelligence, or due diligence question.

Build an Alpha Brief

Request a scoped proposal from this case

Pressure-Testing an Existing Digital Health Portfolio for Fitness to Scale

Is our existing Digital Health portfolio fit for purpose against our updated franchise strategy?

What the client could do next

Approach

Methodology

Strategic interpretation

Overview

Category

Stage

Total Funding

GGA Score